FLIBANSERIN | FLIBANSERIN | ATC G02CX02
NERVOUS SYSTEM TREATMENT OF PREMENOPAUSAL WOMEN WITH ACQUIRED GENERALIZED HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) SEROTONIN RECEPTORS 5-HT1A AGONIST 5-HT2A ANTAGONIST DOPAMINE D4, 5-HT2B AND 5-HT2C (ANTAGONIST WITH MODERATE AFFINITY) | ORAL | Cmax 1.07 MICROMOLAR Tmax .075 HOUR F 33 PERCENT PPB 98 PERCENT HT 11 HOUR SOLUBILITY INSOLUBLE IN WATER | 5-HT1A RECEPTOR 5-HT2A RECEPTOR | 5-hydroxytryptamine receptor 1A UNIPROT P08908 HTR1A -- 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |